Sieve Health
Private Company
Funding information not available
Overview
Sieve Health is a San Francisco-based, AI-driven digital health startup founded in 2020 to address critical inefficiencies in clinical trial recruitment and management. The company's proprietary platform uses advanced algorithms to automate patient-trial matching, site selection, and performance monitoring, aiming to significantly reduce recruitment timelines and operational costs. By focusing on digitization, diversification, decentralization, and democratization of clinical trials, Sieve seeks to accelerate the development of new therapies and improve access for a broader, more representative patient population. The company is a private, likely pre-revenue entity targeting the substantial and growing market for clinical trial optimization technologies.
Technology Platform
Proprietary AI-based platform for clinical trial feasibility, site selection, participant identification, and trial performance management. Focuses on automation to reduce administrative burden, enhance diversity, and enable decentralized trials.
Opportunities
Risk Factors
Competitive Landscape
Sieve competes in a crowded market with large, established clinical trial technology suites (e.g., Veeva, Medidata), internal solutions from major CROs (IQVIA, PPD), and a growing number of AI/ML-focused startups targeting recruitment and trial optimization. Differentiation hinges on proving superior algorithm performance, a focus on diversity, and seamless support for decentralized models.